NCT00122005View on ClinicalTrials.gov

GVAX in Advanced Prostate Cancer Patients Made Lymphopenic

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

GM-CSF gene transduced allogeneic vaccine GVAX

Trial Locations (1)

97213

Providence Portland Medical Center, Portland

Sponsors

Collaborators (1)

Cell Genesys
All Listed Sponsors
collaborator

Providence Cancer Center, Earle A. Chiles Research Institute

OTHER

collaborator

Cell Genesys

INDUSTRY

lead

Providence Health & Services

OTHER